Insider Buying: Johnson Matthey PLC (LON:JMAT) Insider Acquires 14 Shares of Stock

Johnson Matthey PLC (LON:JMATGet Free Report) insider Liam Condon purchased 14 shares of the business’s stock in a transaction that occurred on Tuesday, August 12th. The stock was bought at an average cost of GBX 1,773 ($23.99) per share, for a total transaction of £248.22 ($335.84).

Liam Condon also recently made the following trade(s):

  • On Wednesday, June 18th, Liam Condon acquired 14 shares of Johnson Matthey stock. The shares were bought at an average cost of GBX 1,719 ($23.26) per share, with a total value of £240.66 ($325.61).
  • On Wednesday, May 21st, Liam Condon bought 18 shares of Johnson Matthey stock. The stock was bought at an average price of GBX 1,384 ($18.73) per share, for a total transaction of £249.12 ($337.06).

Johnson Matthey Price Performance

Shares of LON JMAT opened at GBX 1,842 ($24.92) on Friday. The company has a current ratio of 1.45, a quick ratio of 0.76 and a debt-to-equity ratio of 62.73. The company has a market capitalization of £3.08 billion, a price-to-earnings ratio of 31.30, a price-to-earnings-growth ratio of 49,242.50 and a beta of 0.95. Johnson Matthey PLC has a twelve month low of GBX 1,131 ($15.30) and a twelve month high of GBX 1,901 ($25.72). The business has a 50 day simple moving average of GBX 1,784.49 and a 200-day simple moving average of GBX 1,530.76.

Johnson Matthey (LON:JMATGet Free Report) last released its earnings results on Thursday, May 22nd. The company reported GBX 149.20 ($2.02) earnings per share for the quarter. Johnson Matthey had a net margin of 0.84% and a return on equity of 4.49%. As a group, equities research analysts expect that Johnson Matthey PLC will post 173.4112903 earnings per share for the current year.

Wall Street Analyst Weigh In

Separately, Berenberg Bank increased their price target on shares of Johnson Matthey from GBX 1,800 ($24.35) to GBX 1,950 ($26.38) and gave the stock a “hold” rating in a research report on Monday, July 21st.

View Our Latest Stock Report on JMAT

About Johnson Matthey

(Get Free Report)

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.

Recommended Stories

Insider Buying and Selling by Quarter for Johnson Matthey (LON:JMAT)

Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.